|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: Results from a randomized, placebocontrolled, multicentre study (Iressa Survival Evaluation in Lung Cancer)显示文摘 | Thatcher N Chang A Parikh P | 2005 | Lancet2005，366，9496： | 1 |
| 2 | Genome-wide analysis of alternative splicing during development and drought stress in maize 显示文摘 | Thatcher S R Danilevskaya O N Meng X | 2016 | Plant Physiol2016，170，1： | 1 |
| 3 | Reduction of synapsin in the hippocarnpus of patients with bipolar disorder and schizophrenia 显示文摘 | VAWTER M P THATCHER L USEN N | 2002 | Molecular psychiatry2002，7，6： | 1 |
| 4 | Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised placebo-controlled, multicentre study (Iressa Survival Evalua tion in Lung Cancer)显示文摘 | Thatcher N Chang A Parikh P | 2005 | Lancet2005，366，： | 1 |
| 5 | Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer:results from a randomized,placebo-controlled,multicentre study (Iressa Survival Evaluation in Lung Cancer)显示文摘 | Thatcher N Chang A Parikh P | | 0，，9496： | 1 |
| 6 | Zebra fish miR-214modulates Hedgehog signaling to specify muscle cell fate显示文摘 | Flynt A S Li N Thatcher E J | 2007 | Nat Genet2007，39，2： | 1 |
| 7 | Safety and effi-cacy of first-line bevacizumab-based therapy in advanced non-squamous non-small cell lung cancer(SAiL,MO19390):a phase4 study显示文摘 | Crino L Dansin E Garrido P Griesinger F Laskin J Pavlakis N Stroiakovski D Thatcher N Tsai CM Wu YL Zhou C | 2010 | Lancet Oncol2010，11，8： | 1 |
| 8 | Gefitinib plus best supportive care in previously treater patients with refractory advanced non-small cell lung cancer:results from a randomized,placebo controlled,muhicenter study(Iressa Survival Evaluation in Lung Cancer)显示文摘 | Thatcher N Chang A Perikh P | 2005 | Lancet2005，366，9496： | 1 |
| 9 | Gefitinib plus best supportive are in previously treated patients with refractory advanced non-small cell lung carcinoma: results from a randomized, placebo-controlled, multicenter study 显示文摘 | Thatcher N Chang A Parikh P | 2005 | Lancet2005，366，： | 1 |
| 10 | Randomized phase Ⅲ trial of gemcitabine/cisplatin with or without PF-3512676 as first line treatment of advanced non-small cell lung cancer (NSCLG) 显示文摘 | Manegold C Thatcher N Benner R J | 2008 | J Clin Oncol2008，26，： | 1 |
| 11 | Gefitinib plus best supportive care in previously treated patients with refractory advanced non small cell lung cancer results from a randomized placebo controlled multicentre study (Iressa Survival Evaluation In Lung Cancer)显示文摘 | Thatcher N Chang A Parikh P | 2005 | Lancet2005，366，： | 1 |
| 12 | Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer显示文摘 | Thatcher N De Campos ES Bell DR | 1999 | Br J Cancer1999，80，34： | 1 |
| 13 | Quality of life assessment in advanced lung cancer: considerations for evaluation in patients receiving chemotherapy显示文摘 | Gralla RJ Thatcher N | 2004 | Lung Cancer2004，46，2： | 1 |
| 14 | Gefitinib plus kest supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomized, placebocontrolled, multicentre study (Iressa Survival Evaluation in lung cancer)显示文摘 | Thatcher N Chang A Parikh P | 2005 | Lancet2005，366，9496： | 1 |
| 15 | Gefitinib plus best supportive carein previously treated patients with refractory advanced non-small-cell lung cancer: results from a random- ised, placebo-controlled, multicentrestudy (Iressa Survival E- valuation in Lung Cancer) 显示文摘 | Thatcher N Chang A Parikh P | 2005 | Lancet2005，366，9496： | 1 |
| 16 | Erlotinib in non-small cell lung cancer:a review显示文摘 | BLACKHALL FH REHMAN S THATCHER N | 2005 | Expert Opin Pharmacother2005，6，6： | 1 |
| 17 | Gefitinib plus best supportive care in previously treated patients with refractory advanced non - small cell lung cancer: results from a randomized, placebo - controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer) 显示文摘 | Thatcher N Chang A Parikh P | 2005 | Lancet2005，366，： | 1 |
| 18 | The value of tumour markers in lung cancer显示文摘 | Gomm S A Keevil B G Thatcher N | 1988 | Br J Cancer1988，58，6： | 1 |
| 19 | sensitivity and Specificityof immunohistochemical markers used in the diagnosis ofepithelioid mesothelioma : a detailed systematic analysis usingpublished data显示文摘 | King JE Thatcher N Pickering CA | 2006 | Histopathology2006，48，3： | 1 |
| 20 | Gefitinib plus best supportive care in previously treated patients with refaetory advanced non small-cell lung cancer: Results from a random- ised, placebo-controlled, multicentre study (IRESSA survival evaluation in lung cancer)显示文摘 | Thatcher N Chang A Parikh P | 2005 | Lancet2005，366，9496： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员